References
- Di Chiara G, Imperato A. Drugs abused byhumans preferentially increase synaptic dopamineconcentrations in the meso limbic system offreely moving rats. Proc Natl Acad Sci USA1988;85:5274-8.
- Pontieri FE, Francesco E, Tanda G, Francesco0, Di Chiara G. Effects of nicotine on thenucleus accumbens and similarity to those ofaddictive drugs. Nature 1996;382:255-7
- Imperato A, Mulas A, Di Chiara G. Nicotinepreferentially stimulates dopamine release in thelimbic system of freely moving rats. Eur JPharmacol 1986;132: 337-8.
- Damsma G, Day J, Fibiger He. Lack oftolerance to nicotine-induced dopamine releasein the nucleus accumbens. Eur J Pharmacal1989;168:363-8.
- Benwell MEM, Balfour DJK. Comparison of theeffects of constant nicotine infusion on nucleusaccumbens and striatal dopamine responses toacute nicotine. In Clarke PBS, Quik M, ThurauK, Adlkofer F (Eds) The Effects of Nicotine onBiological Systems II. Birkhauser Verlag, Basel,1994: p.66.
- Nisell M, Nomikos GG, Svensson TH. Infusionof nicotine in the ventral tegmental area or thenucleus accumbens of the rat differentiallyaffects accumbal dopamine release. Pharmacol Toxicol 1994;75:348-52.
- Mirza NR, Pei Q, Stolerman IP, Zetterstrom TS.The nicotinic receptor agonists (-)-nicotine andisoarecolone differ in their effects on dopaminerelease in the nucleus accumbens. Eur JPharmacal 1996;295 :207 -10.
- Marshall DL, Redfern PH, Wonnacott S.Presynaptic nicotine modulation of dopaminerelease in the three ascending pathway studiedby in vivo microdialysis: comparison of naiveand chronic nicotine-treated rats. J Neurochem1997;68: 1511-9.
- Toth E, Sershen H, Hashim A, Vizi ES, LajthaA. Effect of nicotine on extracellular levels ofneurotransmitters assessed by microdialysis invarious brain regions: role of glutamic acid.Neurochem Res 1992;17:265-7l.
- Mifsud JC, Hernandez L, Hoebel BG. Nicotineinfused into the nucleus accumbens increasessynaptic dopamine as measured by in vivomicrodialysis. Brain Res 1989;478:365-7.
- Nakamura S, Goshima Y, Yue JL, Miyamae T,Misu Y. Transmitter-like 3,4-dihydroxyphenylalanineis tonically released by nicotine in striataof conscious rats. Eur J Pharmacol 1992;222:75-80.
- Benwell MEM, Balfour DJK. The effects ofacute and repeated nicotine treatment on nucleusaccumbens dopamine and locomotor activity. BrJ Pharmacol 1992; 105:849-56.
- Corrigall WA, Franklin KB, Coen KM, ClarkePB. The mesolimbic dopamine system isimplicated in the reinforcing effects of nicotine.Psychopharmacology 1992; 107 :285-9.
- Clarke PB, Fu DS, Jakubovic A, Fibiger He.Evidence that mesolimbic dopaminergic activationunderlies the locomotor stimulant action ofnicotine in rats. J Pharmacol Exp Ther 1988;246:701-8.
- Tsang D, Yeung HW, Tso WW, Peck H. Ginseng saponins: Influence on neurotransmitterin rat brain synaptosomes. Planta Med 1985;3:221-4.
- Oh KW, Kim HS, Wagner GC. Ginseng totalsaponin inhibits the dopaminergic depletionsinduced by methamphetamine. Planta Med 1997;63:80-l .
- Kim HS, Kang JG, Rheu HM, Cho DH, OhKW. Blockade by ginseng total saponin of thedevelopment of methamphetamine reversetolerance and dopamine receptor supersensitivityin mice. Planta Med 1995;61:22-5.
- Kim HS, Kang JG, Seong YH, Nam KY, OhKW. Blockade by ginseng total saponin of thedevelopment of cocaine induced reversetolerance and dopamine receptor supersensitivityin mice. Pharmacol Biochem Behav 1995;50:23-7.
- Kim HS, Kang JG, Oh KW. Inhibition byginseng total saponin of the development ofmorphine reverse tolerance and dopamine receptorsupersensitivity in mice. Gen Pharmacol1995;26: 1071-6.
- Tokuyama S, Oh KW, Kim HS, Takahashi M,Kaneto H. Blockade by ginseng extract of thedevelopment of reverse tolerance to the ambulation-accelerating effect of methamphetamine inmice. Jpn J Pharmacol 1992;59:423-5.
- Kim HS, Jang CG, Park WK, Oh KW, RheuHM, Cho DH, Oh S. Blockade by ginseng totalsaponin of methamphetamine-induced hyperactivityand conditioned place preference in mice.Gen Pharmacol 1996;27:199-204.
- Tachikawa E, Kudo K, Kashimoto T, TakahashiE. Ginseng saponins reduce acetylcholine-evokedNa + influx and catecholamine secretion in bovineadrenal chromaffin cells. J Pharmacol Exp Ther1995;273:629-36.
- Ando T, Tanaka 0, Shibata S. Chemical studieson the saponins and sapogenins of ginseng and related crude drugs. Syoyakugaku Zasshi 1971;25:28-32.
- 고성룡, 김석창, 최강주. 홍삼의 알콜 농도별 추출 엑스의 수율과 사포닌 함량. 생약학회지 1992;23:24-8.
- Paxinos G, Watson C. The rat brain instereotaxic coordinates. 2nd ed. Academic Press,New York, 1986.
- Nisell M, Nomikos GG, Hertel P, Svensson TH.Acute nicotine administration differentiallyaffects mesolimbic and mesocortical dopamineactivity. In Clarke PBS, Quik M, Thurau K,Adlkofer F (Eds) The Effects of Nicotine onBiological Systems II. Birkhauser Verlag, Basel,1994: p.74.
- Nisell M, Nomikos GG, Svensson TH. Systemicnicotine-induced dopamine release in the ratnucleus accumbens is regulated by nicotinicreceptors in the ventral tegmental area. Synapse1994;16:36-44.
- Giorguieff-Chesselet MF, Kernel ML, WandscheerD, Glowinski J. Regulation of dopaminerelease by presynaptic nicotinic receptors in ratstriatal slices: effect of nicotine in a lowconcentration. Life Sci 1979;25:1257-62.
- Rapier C, Lunt GG, Wonnacott S. Stereoselectivenicotine-induced release of dopamine fromstriatal synaptosomes: concentration dependenceand repetitive stimulation. J Neurochem 1988;50: 1123-30.
- Grady S, Marks MJ, Wonnacott S, Collins AC.Characterization of nicotinic receptor-mediatedeH]dopamine release from synaptosomes preparedfrom mouse striatum. J Neurochem1992;59: 848-56.
- EI-Bizri H, Clarke PB. Blockade of nicotinicreceptor-mediated release of dopamine fromstriatal synaptosomes by chlorisondamine andother nicotinic antagonists administered in vitro.Br J Pharmacol 1994;111:406-13.
- Whiteaker P, Garcha HS, Wonnacott S, StolermanIP. Locomotor activation and dopaminerelease produced by nicotine and isoarecolone inrats. Br J Pharmacal 1995;116:2097-105.
- Sacaan AI, Dunlop JL, Lloyd GK. Pharmacologicalcharacterization of neuronal acetylcholinegated ion channel receptor-mediated hippocampalnorepinephrine and striatal dopamine releasefrom rat brain slices. J Pharmacal Exp Ther1995;274:224-30.
- Sacaan AI, Menzaghi F, Dunlop JL, Correa LD,Whelan KT, Lloyd GK. Epibatidine: a nicotinicacetylcholine receptor agonist releases monoaminergicneurotransmitters: in vitro and in vivaevidence in rats. J Pharmacal Exp Ther 1996;276:509-15.
- McGehee DS, Heath MJ, Gelber S, Devay P,Role LW. Nicotine enhancement of fast excitatorysynaptic transmission in CNS by presynapticreceptors. Science 1995;269:1692-6.
- Ishikawa K, Kano T. Influences of extracellular calcium and potassium concentrations on adrenalinerelease and membrane potential in theperfused adrenal medulla of the rat. Jpn JPhysial 1978;28:275-89.
- Mugnaini E, Oertel WHo An atlas of thedistribution of GABAergic neurons and terminalsin the rat CNS as revealed by GAD immunohistochemistry.In Bjorklund A, Hokfelt T (Eds)Handbook of Chemical Neuroanatomy, Vol. 4,GABA and Neuropeptides in the CNS, Part 1.Elsevier, Amsterdam, 1985: pp.436-608.
- Smolders I, De Klippel N, Sarre S, Ebinger G,Michotte Y. Tonic GABA-ergic modulation ofstriatal dopamine release studied by in vivamicrodialysis in the freely moving rat. Eur JPharmacal 1995;284:83-9l .
- Kimura T, Saunders PA, Kim HS, Rheu HM,Oh KW, Ho IK. Interactions of ginsenosideswith ligand-bindings of GABAA and GABAsreceptors. Gen Pharmacal 1994;25:193-9.